A Cardiology Heparin Dosing Protocol

Hospital Pharmacy

Volumn 31, Issue 12, 1996, Pages 1596-1602

  Rainville, Edward C ^a   Airoldi, Maria R ^b   Sheehey, Jean M ^c   Battle, Robert W ^d  

^a FLETCHER ALLEN HEALTH CARE   (United States)

^b Dept of Pharmacotherapy

^c Univ of Vermont School of Medicine ^*

^d UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

activated partial thromboplastin time (APTT); coronary thrombolysis; heparin

Indexed keywords

HEPARIN;

ACUTE HEART INFARCTION; ANGIOPLASTY; BLOOD CLOT LYSIS; BODY WEIGHT; CLINICAL PROTOCOL; CORONARY ARTERY; DOSE CALCULATION; DRUG MONITORING; HEPARINIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NURSE; PARTIAL THROMBOPLASTIN TIME; REVIEW; THROMBOEMBOLISM; UNSTABLE ANGINA PECTORIS;

EID: 0030454610     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (19)

1. Hull RD, Raskob GE, Rosenbloom D, Lemaire J, Pineo GE Baylis B, et al. Optimal therapeutic level of heparin therapy in patients with venous thrombosis. Arch Intern Med. 1992;152:1589-1595.
2. Hull RD, Raskob GE, Hirsh J, Jay RM, Leclerc JR. Geerts WH et al. Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. N Engl J Med. 1986;315:1009-1014.
3. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329: 673-682.
4. Raschke RA, Reilly BM, Guidry JR, Fontana JR, Srinivas S. The weight-based heparin dosing nomogram compared with a "Standard Care" nomogram. Ann Intern Med. 1993;119:874-381.
5. Carter BL. Therapy of acute thromboembolism with heparin and warfarin. Clin Pharm. 1991;10:503-518.
6. Saya FG, Coleman LT, Martinoff JT. Pharmacist-directed heparin therapy using a standard dosing and monitoring protocol. Am Hosp Pharm. 1985;42:1965-1969.
7. Nemeth JS, Marxen TL, Piltz GW. Weight-based protocol for improving heparin therapy. Am J Health-Syst Pharm 1996;53: 1164-1166.
8. Gunnarsson PS, Sawyer WT, Montague D, Williams ML, Dupuis RE, Caiola SM. Appropriate use of heparin. Empiric vs. nomogram-based dosing Arch Intern Med. 1995;155:526-532
9. Becker RC, Corrao JM, Ball SP, Gore JM. A comparison of heparin strategies after thrombolytic therapy. Am Heart J. 1993;126:750-752.
10. Prins MH, Hirsh J. Heparin as an adjunct treatment after thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1991;67:3A-11A.
11. Popma JJ, Coller BS, Magnus Ohman M, Bittl JA, Weitz J, Kuntz RE et al. Antithrombotic therapy in patients undergoing coronary angioplasty. Chest. 1995:108(suppl): 486S-501S.
12. McMurray J, Rankin A. Cardiology I. Treatment of myocardiai infarction, unstable angina and angina pectoris. Brit Med J. 1994;309:1343-1350.
13. Hirsh J, Fuster V. Guide to anticoagulant therapy Part 1. Heparin. Circulation. 1994; 89:1449-1468.
14. Cipolle RJ, Rodvold KA. Heparin, In Evans WE, Schentag JJ, Jusko WJ eds. Applied Pharmacokinetics: Principles of therapeutic drug monitoring. 3rd ed. Spokane: Applied Therapeutics, Inc.; 1992.
15. Beermann B, Lahnborg G. Pharmacokinetics of heparin in healthy and obese subjects and in combination with dihydroergotamine. Thromb Haemost. 1981:45:24-26.
16. Rivey MP, Peterson JP. Pharmacy managed, weight-based heparin protocol Am J Hosp Pharm. 1993:50:279-284.
17. Aminoglycoside antibiotics. In: Winter ME, Koda-Kimble MA, Young LY eds. Basic Clinical Pharmacokinetics. 3rd ed. Vancouver: Applied Therapeutics. Inc.; 1994, 128-176.
18. Granger CB, Hirsh J, Califf RM, Col J, White HD, Betriu A, et al. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction. Results from GUSTO-I trial. Circulation. 1996;93:870-878.
19. Becker RC, Cannon CP,Tracy RP,Thompson B, Bovill EG, Desvigne-Nickens, P, et al Relation between systemic anticoagulation as determined by activated partial thromboplastin time and heparin measurements and in-hospital clinical events in unstable angina and non-Q wave myocardial infarction. Am Heart J. 1996;131:421-433